Non-muscle invasive bladder cancer has a high recurrence rate, but this treatment offers an additional way to stop it from progressing to a deadlier muscle invasive cancer.
Category: Oncology Innovations
Karen Ballen, MD, international expert in stem cell transplant and alternative donor transplant (transplant from donors that are not perfect matches), explains how it's possible.
UVA Health is among the first in the U.S. to offer BiTE therapy to small cell lung cancer patients in the outpatient setting.
Targeting the transcription factors that drive certain cancers could lead to more effective, less toxic treatments.
This tool guides women on when to add MRI to their breast cancer screening regiment.
Dr. Duska's goal is for every GYN cancer patient at UVA Health to have the opportunity to participate in a clinical trial.
The discovery of an unexpected oocyte protein on the surface of cancer cells may lead to new treatments for pancreatic, ovarian, and other cancers.
UVA Cancer Center researchers lead acute myeloid leukemia (AML) discovery that could pave the way for improved treatments and patient outcomes.
Two new brain tumor medications could make a significant difference in the way tumors are treated — and in the lives of patients.
Learn how her research could lead to new and better life-saving treatments for ovarian and pancreatic cancers.